Innovative directions of CKD prevention and treatment

Keywords: chronic kidney disease, patient-oriented care, innovations, renal education

Abstract

Chronic kidney disease (CKD) is global challenge of health-care. Existence of CKD significantly increases total lethality risk as well as cardiovascular mortality risk. The issue is that current methodology does not ensure prevention, early detection of CKD and avoidance of it progression.
Innovative patient-oriented approaches for solution of these issues must be realized through implementation of national screening programs, IT CKD self-testing, development of CKD-oriented drugs for new therapeutic targets.
If mentioned above problems will be solved, innovative modalities of prevention of steady progression of CKD and the new forms of medical care organization, at least, will help to decrease the level of CKD morbidity and decelerate it progression.

Downloads

Download data is not yet available.

References

Wong LY, Liew AST, Weng WT, Lim CK. et al. Projecting the Burden of Chronic Kidney Disease in a Developed Country and Its Implications on Public Health. International Journal of Nephrology. 2018; Article ID 5196285:1-9. doi:  10.1155/2018/5196285

Levin A, Steven S, Selina A, Flora A, Sarah G, Braden M. Canadian chronic kidney disease clinics: A national survey of structure, function and models of care. Can J Kidney Health Dis. 2014; 1: 29. doi: 10.1186/s40697-014-0029-2  

Levin A, Adams E, Barrett BJ, et al. Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD): Form and Function. Can J Kidney Health Dis. 2018; 5. doi:10.1177/2054358117749530.

Canadian Institutes of Health Research. Canada’s Strategy for Patient-Oriented Research: Improving health outcomes through evidence-informed care. 2011; Available at:  http://www.cihr-irsc.gc.ca/e/documents/P-O_Research_Strategy-eng.pdf

Alberta Innovates Health Solutions. Performance management and evaluation: defining the research-to-impact framework. 2017.   Available at: http://www.aihealthsolutions.ca/media/2012-PME_Framework-brochure.pdf.

Collister D,  Russell R, Verdon J, et al. Perspectives on optimizing care of patients in multidisciplinary chronic kidney disease clinics. Can J Kidney Health Dis. 2016; 3:32. doi:   10.1186/s40697-016-0122-9

Bear RA, Stockie S. Patient engagement and patient-centred care in the management of advanced chronic kidney disease and chronic kidney failure. Can J Kidney Health Dis. 2014; 1:24. doi: 10.1186/s40697-014-0024-7 

Tong A, Cheung K, Nair S, et al. Thematic Synthesis of Qualitative Studies on Patient and Caregiver Perspectives on End-of-Life Care in CKD. Am J Kidney Dis. 2014;63(6):913–927. doi: 10.1053/j.ajkd.2013.11.017

Tiffin-Richards FE, Costa AS, Holschbach B, et al. The Montreal Cognitive Assessment (MoCA) a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. PLoS One. 2014; 9(10): e106700. doi: 10.1371/journal.pone.0106700.

National Institute on Aging. Talking with your older patient.  Available from: https://www.nia.nih.gov/

Morony S, Flynn M, McCaffery KJ, Jansen J, Webster AC. Readability of written materials for CKD patients: A systematic review. Am J Kidney Dis. 2015; 65(6):842–850. doi: 10.1053/j.ajkd.2014.11.025.  

Levin A, Tonelli M, Bonventre J, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet 2017; 390:1888–917. doi: 10.1016/S0140-6736(17)30788-2. 

Crowley ST, Meyer L. Sparking Innovation To Improve the Lives of People with Kidney Disease. CJASN. September 2017; 12 (9): 1548-1550. doi: 10.2215/CJN.04420417

Petzel R. VHA Strategic Plan, FY 2013- 2018. 2012; Available at:  https://www.va.gov/health/docs/VHA_STRATEGIC_PLAN_FY2013-2018.pdf.

Crowley ST, Belcher J, Choudhury D, et al. Targeting access to kidney care via telehealth: The VA experience. Adv Chronic Kidney Dis. 2017; 24:22 30. doi: 10.1053/j.ackd.2016.11.005.  

Monaco K. Annual VA Spending for CKD Steadily Increasing. MedPage Today. 2017 Available at: https://www.medpagetoday.com/meetingcoverage/nkf/64668>. Accessed April 20 2017.

United States Renal Data System. 2015 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2015; Available at: https://www.usrds.org/2015/view/. Accessed April 17 2017.

Ketchersid T. The Move to Value Based Care. 2018; Available at: https://newsroom.fmcna.com/features/top-5-innovations-for-patients-with-end-stage-renal-disease. Accessed March 28 2018.

Hymes J. The Home Dialysis Evolution. 2018; Available at: https://newsroom.fmcna.com/features/top-5-innovations-for-patients-with-end-stage-renal-disease. Accessed March 2018.

Sor M. Improved Vascular Access for Hemodialysis. 2018; Available at:  https://newsroom.fmcna.com/features/top-5-innovations-for-patients-with-end-stage-renal-disease. Accessed March 2018.

Maddux F. Creating Insight from Information. 2018; Available at: https://newsroom.fmcna.com/features/top-5-innovations-for-patients-with-end-stage-renal-disease. Accessed March 2018.

Fissell RB, Karaboyas A, Bieber BA, et al. Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: Findings from the DOPPS. Hemodial Int. 2015;20(1):38-49. doi: 10.1111/hdi.12315.

Pollock C, Zuk A, Anders H-J, et al. The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease. Kidney International Supplement. 2018; 7(2):130–137. doi: 10.1016/j.kisu.2017.07.008

Bello AK, Levin A, Tonelli M, et al. Assessment of global kidney health care status. JAMA. 2017; 317:1864 – 1881. doi:  10.1001/jama.2017.4046.


Abstract views: 106
PDF Downloads: 55
Published
2019-02-13
How to Cite
Kolesnyk, M. (2019). Innovative directions of CKD prevention and treatment. Ukrainian Journal of Nephrology and Dialysis, (1(61), 3-12. https://doi.org/10.31450/ukrjnd.1(61).2019.01